CMTM6 and pancreatic neoplasm: Two studies using CRISPR‒Cas9-mediated loss-of-function screening in pancreatic cancer cells5 and haploid genetic screening in HAP1 cells6 identified CKLF-like MARVEL transmembrane domain containing 6 (CMTM6) as a PD-L1 enhancer.